Pamela Connealy - Dec 6, 2021 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role
Chief Financial Officer
Signature
/s/ Pamela Connealy
Stock symbol
PYXS
Transactions as of
Dec 6, 2021
Transactions value $
$0
Form type
4
Date filed
12/7/2021, 02:36 PM
Previous filing
Oct 7, 2021
Next filing
Apr 4, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PYXS Stock Option (Right to buy) Award $0 +52.9K $0.00 52.9K Dec 6, 2021 Common Stock 52.9K $9.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options vest 25% on July 19, 2022, and then in 36 substantially-equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.